Cannabidiol and epilepsy in Brazil: a current review
Abstract Background: Cannabidiol (CBD) has become a promising therapeutic option in the treatment of epilepsy. Recent studies provide robust evidence…
Abstract Background: Cannabidiol (CBD) has become a promising therapeutic option in the treatment of epilepsy. Recent studies provide robust evidence…
Abstract The prevalence of depression is increasing worldwide, as is the number of people suffering from treatment-resistant depression; these patients…
Abstract Cannabinoid receptor 2 (CB2) is of interest as a much-needed target for the treatment or prevention of several neurogenerative…
Abstract Plant-based natural compounds (PBCs) are comparatively explored in this study to identify the most effective and safe antibacterial agent/s…
Abstract Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging evidence points to CB2 playing…
Abstract CD8A encodes the CD8 alpha chain of αβT cells, which has been proposed as a quantifiable indicator for the…
Abstract We present the case of a 51-year-old male admitted for cardiovascular complications in the face of concomitant chronic methamphetamine…
Abstract Background. Synthetic cannabinoid-related acute kidney injury represents an increasingly important public health issue due to the diagnostic challenges given…
Abstract Toll-like receptor 4 (TLR4) is a pattern-recognition receptor (PRR) that regulates the activation of immune cells, which is a…
Abstract Background: Cannabis is the most widely used illegal drug but is rarely considered a causal factor in death. Aims:…